Clinical Trial

Confirmatory Clinical Study of Treating Tricuspid Regurgitation With K-Clip TM Transcatheter Annuloplasty System

Study acronym: TriStar
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 21, 2022 (before its estimated May 15, 2023 completion). Its status may not reflect the trial's current state.
Summary
The present clinical trial is performed to evaluate the effectiveness and safety of transcatheter tricuspid annuloplasty system manufactured by Shanghai Huihe Healthcare technology Co.,Ltd. for the treatment of subjects with severe or worse tricuspid regurgitation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-12-27.
Trial Details
NCT Number NCT05173233
Lead Sponsor Shanghai Huihe Medical Technology Co., Ltd
Conditions Tricuspid Regurgitation
Enrollment 67 participants
Start Date 2022-05-15
Primary Completion 2023-05-15 (estimated)
Study Completion 2027-05-15 (estimated)
Updated on ClinicalTrials.gov 2022-04-21